technetium-tc-99m-exametazime has been researched along with Toxoplasmosis* in 2 studies
2 other study(ies) available for technetium-tc-99m-exametazime and Toxoplasmosis
Article | Year |
---|---|
Cerebral blood flow in AIDS-related neurotoxoplasmosis: a preliminary 99mTc-HMPAO SPECT study.
Cerebral blood flow (CBF) was evaluated by gamma camera 99mTc-HMPAO SPECT in 11 patients with AIDS-related neurotoxoplasmosis and correlated with neurological findings and the results of CT and MRI. Evident CBF abnormalities were observed in all patients with involvement of at least two cerebral lobes. In 10 patients the abnormalities were bilateral and in 8 patients basal ganglia were involved; no specific hypoperfusion pattern was however evident. Focal lesions were found in 7 patients by CT (sensitivity: 63.6%) and in 10 patients by MRI (sensitivity: 90.9%). It may be concluded that neurotoxoplasmosis in AIDS patients is associated with a high prevalence of focal cortical and subcortical hypoperfusion but that the scintigraphic findings are not specific; that HMPAO SPECT may show focal hypoperfusion in patients with normal CT studies and/or non-focal MRI abnormalities; that the hypoperfusion may be more extensive than the corresponding MRI lesion(s) and that it may be present even in areas with normal MRI signals; and that more experience and longitudinal studies are needed to assess the possible impact of HMPAO SPECT on follow-up and therapy monitoring. Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Diseases; Cerebrovascular Circulation; Female; Humans; Male; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Toxoplasmosis | 1991 |
[EEG and SPECT in cerebral manifestations of AIDS].
The purpose of the presented study was to determine the diagnostic value of correlated EEG and SPECT findings in patients with CNS-manifestations of AIDS. Ten HIV 1 infected patients had been examined. Diagnoses: meningitis (2 x), lymphoma (2 x), necrotizing encephalitis (1 x), toxoplasmosis (7 x) (Some patients had more than one diagnosis). Unenhanced and Gd-DTPA enhanced MR, 99mTc-HM-PAO SPECT and clinical EEG were compared. In 9/10 patients MR demonstrated intracranial lesions. In one patient with necrotizing encephalitis (not detected by MR), SPECT revealed an inhomogeneous cerebral perfusion. Only lymphoma was hyperperfused. Toxoplasmic lesions-when detectable by SPECT-were hypoperfused. Reduced rCBF was also seen in brain regions not affected directly, but functionally associated to altered areas. EEG revealed diffuse signs such as slowing in patients with brain atrophy, but also in those patients with lesions of basal ganglia and thalamus. Focal signs in the EEG were in concordance with imaging findings in only 2/10 patients. In 4/10 patients foci even adjacent to the cortex - as shown by MR - remained undetected by EEG. One patient with an active toxoplasmosis had sharp waves over the affected region. The parallel application of the three methods as suggested in this paper appears useful not only for scientific purposes. In most cases, this procedure provides relevant diagnostic information. It is recommended for AIDS-patients with CNS manifestations of unknown etiology. Topics: Acquired Immunodeficiency Syndrome; Adult; Brain; Brain Diseases; Brain Neoplasms; Electroencephalography; Encephalitis; HIV-1; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Meningitis; Middle Aged; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Toxoplasmosis | 1989 |